Lead Product(s): Sirolimus
Therapeutic Area: Dermatology Product Name: Pascomer
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Timber Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement March 17, 2021
Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe.